Company Filing History:
Years Active: 2022-2023
Title: Rachel Storr: Innovator in LDHA Expression Inhibition
Introduction
Rachel Storr is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of inhibiting the expression of LDHA. With a total of 2 patents, her work has the potential to impact various therapeutic applications.
Latest Patents
Storr's latest patents focus on methods and compositions for inhibiting the expression of LDHA. This disclosure relates to oligonucleotides, compositions, and methods that are useful for reducing LDHA expression, particularly in hepatocytes. Her innovative approaches aim to provide new avenues for treatment in related medical conditions.
Career Highlights
Throughout her career, Rachel Storr has worked with notable companies such as Dicerna Pharmaceuticals, Inc. and Novo Nordisk Healthcare AG. Her experience in these organizations has allowed her to develop and refine her expertise in biotechnology and patentable innovations.
Collaborations
Some of her coworkers include Bob Dale Brown and Henryk T Dudek. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.
Conclusion
Rachel Storr is a dedicated inventor whose work in inhibiting LDHA expression showcases her commitment to advancing biotechnology. Her contributions are paving the way for future innovations in medical treatments.